Stocktoria

Altimmune, Inc. ALT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2005-10-06 · LEI

Altimmune, Inc. statistics & valuation

Market cap$548.4M
P / B2.4×
Net margin-214861.0%
Return on equity-39.2%
FCF margin-164746.3%
Net cash$9.5M
Enterprise value USD$538.9M
Earnings yield EBIT/EV-17.5%
Return on capital-35.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-342.60% -432.30% -379.20% -353.70% -599.20% -2201.40% -20762.20% -475295.00% -214861.00% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-342.70% -484.70% -414.60% -370.00% -669.50% -2197.40% -22518.50% -515860.00% -230461.00% 2016201720182019202020212022202320242025
Return on equity (%)
-34.40% -117.80% -81.10% -45.10% -21.70% -48.80% -45.70% -45.60% -77.00% -39.20% 2016201720182019202020212022202320242025
Shares outstanding
65.7M 608499 9.1M 15.3M 37.1M 41.3M 49.2M 70.7M 72.4M 110.9M 2016201720182019202020212022202320242025
Net debt ($)
-$2.4M -$8.2M -$31.9M -$7.1M -$114.1M -$188.8M -$106.5M -$9.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-28.90% -73.70% -71.50% -38.00% -20.00% -44.40% -40.90% -42.00% -68.20% -31.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-200.20% -189.30% -100.30% -165.50% -421.60% -2048.70% -17806.80% -164746.30% 2016201720182019202020212022202320242025
Debt / equity (×)
0.02× 0.02× 0.04× 0.04× 0.01× 0.01× 0.02× 0.15× 2016201720182019202020212022202320242025
EPS ($)
$2.95 -$1.91 -$2.35 -$1.81 -$1.66 -$1.34 -$1.00 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-230461.0%-515860.0%-22518.5%129029.4%-2197.4%-669.5%-370.0%-414.6%-484.7%-342.7%
Net margin-214861.0%-475295.0%-20762.2%124577.9%-2201.4%-599.2%-353.7%-379.2%-432.3%-342.6%
FCF margin-164746.3%—-17806.8%92223.5%-2048.7%-421.6%-165.5%-100.3%-189.3%-200.2%
Return on assets-31.5%-68.2%-42.0%-40.9%-44.4%-20.0%-38.0%-71.5%-73.7%-28.9%
Return on equity-39.2%-77.0%-45.6%-45.7%-48.8%-21.7%-45.1%-81.1%-117.8%-34.4%
Debt / equity0.15×——0.02×0.01×0.01×0.04×0.04×0.02×0.02×
Current ratio18.5513.1117.2611.3111.1719.1610.048.706.110.82

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.